These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt||2004-005247-10||PHASE I STUDIES OF TARCEVATM (ERLOTINIB HYDROCHLORIDE, OSI-774) AS SINGLE AGENT IN CHILDREN WITH REFRACTORY AND RELAPSED MALIGNANT BRAIN TUMORS AND IN COMBINATION WITH IRRADIATION IN NEWLY DIAGNOSED M...||2008-12-03||not-yet-due|
|Not reported||2005-003962-40||An open label, Phase II study of biweekly VELCADETM and intermittent CAELIXTM in patients with ovarian cancer failing platinum containing regimens||2009-07-07||due-trials|